Evidence map›Paper›PMID 29896192›Full record

ReviewFrontiers in immunology2018

Outgrowing the Immaturity Myth: The Cost of Defending From Neonatal Infectious Disease.

Danny Harbeson, Rym Ben-Othman, Nelly Amenyogbe, Tobias R Kollmann

Abstract readReview
In one paragraph

Review in Frontiers in immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed.

  1. Article
  2. The HIV Reservoir and Immune Landscape Across the Life Course of Women: Implications for Cure Strategies.American journal of reproductive immunology (New York, N.Y. : 1989) · 2026
    Review
  3. Article
  4. Review
  5. Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  6. Observational
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Danny HarbesonDepartment of Experimental Medicine, University of British Columbia, Vancouver, BC, Canada.
Rym Ben-OthmanDepartment of Pediatrics, Division of Infectious Diseases, University of British Columbia, Vancouver, BC, Canada.
Nelly AmenyogbeDepartment of Experimental Medicine, University of British Columbia, Vancouver, BC, Canada.
Tobias R KollmannDepartment of Experimental Medicine, University of British Columbia, Vancouver, BC, Canada.

Funding

Transcriptomics to define biomarkers of neonatal vaccine immunogenicityU19AI118608 · NIAID · BOSTON CHILDREN'S HOSPITAL · PI OZONOFF, AL · 2017 to 2021
$24.7M
NIAID NIH HHS U19 AI118608
6 · The paper itself

Abstract

Newborns suffer high rates of mortality due to infectious disease-this has been generally regarded to be the result of an "immature" immune system with a diminished disease-fighting capacity. However, the immaturity dogma fails to explain (i) greater pro-inflammatory responses than adults

Indexed as

ImmunityAge FactorsAnimalsCommunicable DiseasesDisease ResistanceDisease SusceptibilityHost-Pathogen InteractionsHumansImmune ToleranceInfant, NewbornInfant, Newborn, DiseasesMicrobiotaTranslational Research, Biomedicaldefenseinfectionneonatesepsistolerance

Identifiers

PMID29896192
PMCPMC5986917

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.